Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
March 15, 2021
Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic Model
Essa Hu, Fang-Tsao Hong, Jennifer Aral, et al.
Plos One
|
May 4, 2018
Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V
Bryan D Moyer, Justin K Murray, Joseph Ligutti, et al.
Journal of Medicinal Chemistry
|
October 23, 2018
Discovery of Tarantula Venom-Derived Na<sub>V</sub>1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis
Bin Wu, Justin K Murray, Kristin L Andrews, et al.
Journal of the American Chemical Society
|
October 6, 2007
A chemical approach to the pharmaceutical optimization of an anti-HIV protein
Les P Miranda, Haiyan Shao, Jason Williams, et al.
Journal of Medicinal Chemistry
|
April 6, 2026
Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of Obesity
Bin Wu, James R Falsey, Chawita Netirojjanakul, et al.
Process Biochemistry (Barking, London, England)
|
April 4, 2023
Process development of a SARS-CoV-2 nanoparticle vaccine
Diandra Martinez-Cano, Rashmi Ravichandran, Huong Le, et al.
Journal of Medicinal Chemistry
|
August 20, 2015
Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3
Justin K Murray, Yi-Xin Qian, Benxian Liu, et al.
ACS Chemical Biology
|
August 12, 2017
Engineering Antibody Reactivity for Efficient Derivatization to Generate Na<sub>V</sub>1.7 Inhibitory GpTx-1 Peptide-Antibody Conjugates
Kaustav Biswas, Thomas E Nixey, Justin K Murray, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 8, 2019
Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical Species
Robert S Foti, Kaustav Biswas, Jennifer Aral, et al.
Science (New York, N.Y.)
|
February 8, 2003
Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein
Gerd G Kochendoerfer, Shiah-Yun Chen, Feng Mao, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
March 15, 2021
Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic Model
Essa Hu, Fang-Tsao Hong, Jennifer Aral, et al.
Plos One
|
May 4, 2018
Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V
Bryan D Moyer, Justin K Murray, Joseph Ligutti, et al.
Journal of Medicinal Chemistry
|
October 23, 2018
Discovery of Tarantula Venom-Derived Na<sub>V</sub>1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis
Bin Wu, Justin K Murray, Kristin L Andrews, et al.
Journal of the American Chemical Society
|
October 6, 2007
A chemical approach to the pharmaceutical optimization of an anti-HIV protein
Les P Miranda, Haiyan Shao, Jason Williams, et al.
Journal of Medicinal Chemistry
|
April 6, 2026
Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of Obesity
Bin Wu, James R Falsey, Chawita Netirojjanakul, et al.
Process Biochemistry (Barking, London, England)
|
April 4, 2023
Process development of a SARS-CoV-2 nanoparticle vaccine
Diandra Martinez-Cano, Rashmi Ravichandran, Huong Le, et al.
Journal of Medicinal Chemistry
|
August 20, 2015
Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3
Justin K Murray, Yi-Xin Qian, Benxian Liu, et al.
ACS Chemical Biology
|
August 12, 2017
Engineering Antibody Reactivity for Efficient Derivatization to Generate Na<sub>V</sub>1.7 Inhibitory GpTx-1 Peptide-Antibody Conjugates
Kaustav Biswas, Thomas E Nixey, Justin K Murray, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 8, 2019
Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical Species
Robert S Foti, Kaustav Biswas, Jennifer Aral, et al.
Science (New York, N.Y.)
|
February 8, 2003
Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein
Gerd G Kochendoerfer, Shiah-Yun Chen, Feng Mao, et al.
Page
of 5